Hunter C. Smith
2020
In 2020, Hunter C. Smith earned a total compensation of $2.7M as Chief Financial Officer at RHYTHM PHARMACEUTICALS, a 38% increase compared to previous year.
Compensation breakdown
| Bonus | $60,000 |
|---|---|
| Non-Equity Incentive Plan | $209,595 |
| Option Awards | $1,837,630 |
| Salary | $416,118 |
| Stock Awards | $132,000 |
| Other | $7,125 |
| Total | $2,662,468 |
Smith received $1.8M in option awards, accounting for 69% of the total pay in 2020.
Smith also received $60K in bonus, $209.6K in non-equity incentive plan, $416.1K in salary, $132K in stock awards and $7.1K in other compensation.
Rankings
In 2020, Hunter C. Smith's compensation ranked 4,311th out of 13,090 executives tracked by ExecPay. In other words, Smith earned more than 67.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,311 out of 13,090 | 67th |
Division Manufacturing | 1,744 out of 5,621 | 69th |
Major group Chemicals And Allied Products | 681 out of 2,254 | 70th |
Industry group Drugs | 582 out of 1,954 | 70th |
Industry Pharmaceutical Preparations | 442 out of 1,459 | 70th |
Source: SEC filing on April 27, 2023.
Smith's colleagues
We found two more compensation records of executives who worked with Hunter C. Smith at RHYTHM PHARMACEUTICALS in 2020.